ReiThera, a CDMO, has appointed Stefano Colloca as its Chief Executive Officer. Stefano brings decades of experience as a leader in viral vector technologies, having co-founded and directed numerous viral vector programs at Okairos Srl, before co-founding ReThera. As CEO, Stefano will use his strategic insight and deep understanding of ReiThera and its novel vaccine platform to lead the company’s next growth phase and continue work in advancing gene therapy programs for vaccines and advanced...